Browse studies

Find your next paid study

27,407 recruiting studies available now

Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach

The purpose of this study is to understand how placing Amnioeffect on patients having transcutaneous thyroid or parathyroid surgery affects surgery scar appear…

Thyroid; WoundParathyroid DiseasesSurgical Incision+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Sarasota Memorial Health Care SystemNCT07173621

Phase 1

A Phase 1, Multicenter, Open-Label, Dose Escalation, Dose Expansion and Dose Optimization Study of BHV-1530 as Monotherapy and in Combination With Other Anti-Cancer Agents in Adult Participants With Advanced or Metastatic Solid Tumors

This is a Phase 1, first in human (FIH), Open-Label, Dose Escalation, Dose Expansion and Dose Optimization Study of BHV-1530 as Monotherapy and in Combination …

Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Biohaven Therapeutics Ltd.NCT06874335

Phase 1

Translational Recording and Characterization of Epilepsy Signals Using Subgaleal EEG During Standard-of-care SEEG Monitoring

TRACE is a record-only study evaluating subgaleal EEG (sgEEG) recorded concurrently with standard-of-care stereoelectroencephalography (SEEG) in adults with dr…

Epilepsy (Treatment Refractory)

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Adraxe Corp.NCT07821697

Phase 1

A Phase I/IIa Multi-center, Open-label Master Protocol Dose Escalation and Expansion Study of AZD8205 as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors (BLUESTAR)

This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-can…

Breast CancerBiliary Tract CarcinomaOvarian Cancer+2 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT05123482

Phase 1

Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder

The primary objective of this multimodal positron emission tomography (PET) study is to use PET brain imaging to measure both MOR (Mu-Opioid receptors) and KOR…

Alcohol Use Disorder

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Yale UniversityNCT05957159

Phase 2

A Phase II Study of the Combination of Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Relapsed Hodgkin Lymphoma (HL) and B-Non-Hodgkin- Lymphoma (B-NHL)

This is a Phase II single-center open label trial of the combination of ATRA and pembrolizumab treatment in patients with histologically proven, relapsed or re…

Relapsed Hodgkin LymphomaRefractory Hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma+2 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Rita AssiNCT06484920

Phase 2

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM). The drugs involved in this study are : * Abemac…

Glioblastoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

David Reardon, MDNCT02977780

Observational

Clinical Outcomes of Modified Coronally Advanced Tunnel Technique With Deepithelialized Connective Tissue Graft for Mandibular Lingual Root Coverage: A Case Series

This study will follow adults who have gum recession on the tongue side of the lower teeth. Participants will receive a gum surgery called the Modified Coronal…

Gingival RecessionMucogingival Deformity - Insufficient Keratinized Tissue

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PittsburghNCT07590960

Phase 1

Phase I/II Study of Tandem, Bispecific Anti-CD19 Anti-CD20 CAR-T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

This is a Phase I/II, interventional, single-arm, open-label, treatment study designed to evaluate the safety and efficacy of Interleukin-7 and Interleukin-15 …

Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Medical College of WisconsinNCT04186520

Phase 1

A Phase 1 Clinical Trial of 64Cu-DOTA A2 scFv-Fc2 DM (64Cu-DOTA-A2DM) Positron Emission Tomography in Patients With Metastatic PSCA-Expressing Pancreatic Cancer

This clinical trial tests the safety, side effects, best dose and feasibility of using 64Cu-DOTA A2 scFv-Fc2 DM with positron emission tomography for the imagi…

Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

City of Hope Medical CenterNCT07608627

Observational

Expanding Access to Evidence-Based Suicide Risk Assessment and Intervention in a Crisis Stabilization Setting (Patient Informants and RCT)

The overarching goal of this project is to expand access to evidence-based suicide risk assessment, safety planning, and intervention among patients at elevate…

SuicideSuicide AttemptRandomized Controlled Trial (RCT)

Estimated

~$10 – $750

Actual pay is set by the research site.

Butler HospitalNCT07864961

Phase 1

A Phase 1b/2, Open-Label, Dose-Finding and Proof of Concept Study of Nenocorilant in Combination With Anti-Programmed Cell Death/(Ligand) 1 in Patients With Advanced Solid Malignancies

This open-label, dose-finding, and proof of concept study will evaluate the safety, tolerability, maximum-tolerated dose (MTD) and/or optimal dose of nenocoril…

Neoplasms

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Corcept TherapeuticsNCT07276373